GURU.Markets stock price, segment price, and overall market index valuation
The company's share price ANI Pharmaceuticals
ANI Pharmaceuticals is a manufacturer of generic and specialty pharmaceuticals. Its share price reflects its strategy of acquiring and relaunching legacy drug brands, as well as the challenges associated with pricing pressure in the generics market.
Share prices of companies in the market segment - Pharma other
ANI Pharmaceuticals is a pharmaceutical company specializing in the production of generic and branded drugs. We classify it in the Pharma Other sector, and the chart below reflects the dynamics of this segment, as well as the success of its acquisition strategy.
Broad Market Index - GURU.Markets
ANI Pharmaceuticals is a pharmaceutical company that manufactures and markets both branded and generic prescription drugs. Its diversified portfolio makes it a prominent component of the GURU.Markets index. The chart below represents the entire market. Find out how ANI compares to it.
Change in the price of a company, segment, and market as a whole per day
ANIP - Daily change in the company's share price ANI Pharmaceuticals
Daily fluctuations in the ANI Pharmaceuticals index, a generic drug manufacturer, reflect the volatility of the pharmaceutical market. change_co measures sensitivity to new drug approvals and price competition. This metric is an important element for analyzing risks in the healthcare sector on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Pharma other
ANI Pharmaceuticals, Inc. is a pharmaceutical company. This chart shows the average daily volatility of the sector. Comparison with ANIP's performance, which focuses on generics and specialty drugs, helps assess its sensitivity to price competition.
Daily change in the price of a broad market stock, index - GURU.Markets
ANI Pharmaceuticals is a manufacturer of generic and specialty pharmaceuticals. The pharmaceutical sector may operate by its own rules, but stocks of such companies are still subject to overall market trends. The chart below provides context for assessing ANI's performance.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization ANI Pharmaceuticals
ANI Pharmaceuticals is a pharmaceutical company specializing in generic and specialty drugs. Its year-over-year performance reflects a complex process of acquisition integration and its strategy of focusing on the most profitable segments.
Annual dynamics of market capitalization of the market segment - Pharma other
ANI Pharmaceuticals, Inc. is a pharmaceutical company specializing in the production of generic and branded drugs. Its growth strategy is based on acquisitions. The chart below shows how its M&A activity and ability to successfully integrate new products impact its growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
ANI Pharmaceuticals, a manufacturer of generic and specialty drugs, operates in the defensive healthcare sector. However, its stock price reflects not only stable demand but also the intense competition and pricing pressure in the generics market. The chart tells the story of the struggle for profitability in the challenging pharmaceutical sector.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization ANI Pharmaceuticals
ANI Pharma, a manufacturer of generic and specialty branded drugs. The monthly fluctuations on the chart reflect the success of new product launches and its strategy of acquiring undervalued pharmaceutical assets.
Monthly dynamics of market capitalization of the market segment - Pharma other
The specialty and generic pharmaceuticals market is a business built on the production and acquisition of pharmaceutical assets. The dynamics of this segment, reflected in the chart, demonstrates the overall investor sentiment toward pharmaceutical companies with diversified portfolios, such as ANI Pharmaceuticals.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
ANI Pharmaceuticals produces generic and branded drugs. Its business is less risky than that of innovative biotech companies, but is subject to pricing pressure. The company's share price performance reflects the balance between stable demand and competition in the generics market.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization ANI Pharmaceuticals
ANI Pharmaceuticals, Inc. produces both brand-name and generic pharmaceuticals. Its weekly stock price is driven by news of the approval and launch of new generic drugs, as well as the results of its efforts to develop and acquire brand-name products.
Weekly dynamics of market capitalization of the market segment - Pharma other
ANI Pharma, with its hybrid model (generics and brands), may have different dynamics than "pure" generics or innovative companies. The chart allows for a comparison with both segments and illustrates how the market views this hybrid strategy and its potential for growth.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
ANI Pharmaceuticals produces both generic and branded medications. The pharmaceutical business is considered "defensive," but competition in the generics market is fierce. The chart shows how these factors influence the company's share price volatility relative to the market.
Market capitalization of the company, segment and market as a whole
ANIP - Market capitalization of the company ANI Pharmaceuticals
The ANI Pharmaceuticals market capitalization chart shows how the market values its business model, which focuses on producing generic and specialized branded drugs. Its market capitalization reflects its success in introducing new products and acquiring existing ones. This is an assessment of its ability to compete in the highly competitive pharmaceutical market.
ANIP - Share of the company's market capitalization ANI Pharmaceuticals within the market segment - Pharma other
ANI Pharmaceuticals maintains its market share by specializing in the production of generic and branded drugs, often in niche categories. Its market capitalization reflects its diversified portfolio and acquisition-led growth strategy.
Market capitalization of the market segment - Pharma other
The graph below shows the market capitalization of the pharmaceutical sector, and ANI Pharmaceuticals occupies a niche within it, producing generic and specialized branded drugs. The dynamics of this market reflect the constant need for affordable medications. ANI grows by acquiring and relaunching existing, but undervalued, pharmaceutical products.
Market capitalization of all companies included in a broad market index - GURU.Markets
ANI Pharmaceuticals is a manufacturer of generic and specialized branded drugs. Its market capitalization reflects its strategy of producing both affordable and niche medications. The chart below shows the economic weight of pharmaceutical companies with a hybrid business model.
Book value capitalization of the company, segment and market as a whole
ANIP - Book value capitalization of the company ANI Pharmaceuticals
ANI Pharmaceuticals' foundation is its US manufacturing facilities for both generic and specialty branded drugs. Its book value reflects this hybrid business model. The chart shows how the company leverages its manufacturing base to launch new products and acquire rights to existing drugs.
ANIP - Share of the company's book capitalization ANI Pharmaceuticals within the market segment - Pharma other
ANI Pharmaceuticals specializes in the production of generic and branded drugs. The chart shows its share of real assets. These include its manufacturing facilities in the US, which allow it to produce a wide range of drugs and compete in the pharmaceutical market.
Market segment balance sheet capitalization - Pharma other
ANI Pharmaceuticals is a manufacturer of generic and branded drugs. Its business is more capital-intensive than that of pure R&D companies, as it requires its own manufacturing facilities in the US. Compared to the pharmaceutical sector, this demonstrates its strategy focused on production and quality control.
Book value of all companies included in the broad market index - GURU.Markets
ANI Pharmaceuticals' assets comprise a diversified portfolio of dozens of generic and specialty drugs. The company's balance sheet reflects the value of its manufacturing facilities and drug production rights. The chart shows the capital behind this pharmaceutical company, which makes treatment more accessible.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - ANI Pharmaceuticals
ANI Pharmaceuticals specializes in the production of generic and branded drugs. Its value lies not only in its production lines but also in its portfolio of approved drugs and pipeline of new products. Its market capitalization reflects the company's ability to successfully launch new drugs and compete in the pharmaceutical industry.
Market to book capitalization ratio in a market segment - Pharma other
ANI Pharmaceuticals produces both branded and generic drugs. The company combines predictable revenue from generics with the growth potential of new products. This chart shows how the market values this hybrid model, balancing stability with a premium for future developments.
Market to book capitalization ratio for the market as a whole
ANI Pharmaceuticals produces and markets generic and branded pharmaceuticals. The company's business combines manufacturing capacity and a portfolio of drug approvals. This chart shows how the market evaluates this balanced model in the pharmaceutical industry compared to overall market indicators.
Debts of the company, segment and market as a whole
ANIP - Company debts ANI Pharmaceuticals
ANI Pharmaceuticals is a manufacturer of generic and branded pharmaceuticals. The company's strategy includes both developing its own products and acquiring rights to existing drugs. Debt financing can be used to finance such transactions and expand production capacity.
Market segment debts - Pharma other
ANI Pharmaceuticals produces generic and branded pharmaceuticals. Growth strategies in this sector often involve acquiring products or companies. This chart shows how ANI uses debt financing to expand its product portfolio and manufacturing capacity while competing in the pharmaceutical market.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio ANI Pharmaceuticals
ANI Pharmaceuticals is a pharmaceutical company specializing in the production of generic and branded drugs. This chart illustrates its acquisition-based growth strategy. The debt level here often reflects funding for the acquisition of new products or production facilities, allowing the company to expand its portfolio and diversify its revenue.
Market segment debt to market segment book capitalization - Pharma other
ANI Pharmaceuticals produces both branded and generic pharmaceuticals. This chart reflects debt trends in the diversified pharmaceutical industry. It helps understand how the company uses debt to finance acquisitions and new product development, balancing market segments.
Debt to book value of all companies in the market
ANI Pharmaceuticals, as a generic drug manufacturer, operates in a relatively stable sector. This chart reflects debt trends across the economy. It helps understand the extent to which the healthcare sector, and pharmaceuticals in particular, is "defensive" and how its debt policy differs from more cyclical industries.
P/E of the company, segment and market as a whole
P/E - ANI Pharmaceuticals
This chart for ANI Pharmaceuticals, a manufacturer of generic and specialty drugs, evaluates its growth strategy. The price-to-earnings ratio shows how confident investors are in the company's ability to successfully launch new drugs and manage its diverse portfolio. The dynamics reflect the balance between its stable generics business and riskier developments.
P/E of the market segment - Pharma other
This chart shows the average valuation for the pharmaceutical industry—the benchmark for ANI Pharma. Comparing this company's valuation, which produces both generic and branded drugs, to the industry average helps understand how investors view its blended business model and ability to generate sustainable growth.
P/E of the market as a whole
ANI Pharmaceuticals produces both branded and generic drugs, focusing on niche markets. It operates under a diversified pharmaceutical model. This chart of overall healthcare sector sentiment helps understand what investors value more: the growth potential of new brands or the stability and cash flow of generics, especially during periods of uncertainty.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company ANI Pharmaceuticals
ANI Pharmaceuticals produces both branded and generic medications. The company's future profitability depends on the successful launch of new generics and sales growth of existing brands. This chart shows analyst forecasts regarding the competitive environment in the generics market and the potential of the company's portfolio.
%20P%2FE%20ANI%20Pharmaceuticals&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-ANI-Pharmaceuticals&v=1772640769652 "Chart of the company's future (projected) P/E ANI Pharmaceuticals")
Future (projected) P/E of the market segment - Pharma other
ANI Pharmaceuticals produces both branded and generic pharmaceuticals. Its valuation relative to other pharmaceutical companies reflects how the market views its diversified business model. This reflects investors' opinions on its ability to successfully launch new generics and manage its brand portfolio.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-other&v=1772640769741 "Future (projected) P/E graph of the market segment - Pharma other")
Future (projected) P/E of the market as a whole
ANI Pharmaceuticals produces both branded and generic medications. This is a diversified business model in the pharmaceutical industry. This chart shows the overall investor sentiment that influences the valuation of the entire healthcare sector. It helps understand how the market currently views stable generic companies versus risky biotechs.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772640769765 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit ANI Pharmaceuticals
ANI Pharmaceuticals specializes in the production of generic and branded pharmaceuticals. Financial results, illustrated by this chart, depend on the successful launch of new generic drugs and stable demand for the existing portfolio. Strategic acquisitions also play a significant role.
Profit of companies in the market segment - Pharma other
ANI Pharmaceuticals produces both branded and generic pharmaceuticals. This chart shows the overall profitability of the pharmaceutical industry. It helps assess the success of the hybrid business model in the face of pricing pressure on generics and high brand promotion costs, and how this compares to the overall market.
Overall market profit
ANI Pharmaceuticals is a manufacturer of generic and specialty branded medications. Its business consists of acquiring and relaunching legacy drugs, as well as developing its own products. ANIP's success depends on its M&A strategy and FDA approvals. This niche market is less susceptible to the general economic cycles illustrated by this chart.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company ANI Pharmaceuticals
ANI Pharmaceuticals develops and manufactures both branded and generic prescription drugs. Its future profitability depends on the successful launch of new products, patent renewals, and competition in the generics market. This chart shows how analysts assess the potential of its portfolio and the company's ability to grow its market share.
%20profit%20of%20the%20company%20ANI%20Pharmaceuticals&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-ANI-Pharmaceuticals&v=1772640769965 "Graph of future (projected) profit of the company ANI Pharmaceuticals")
Future (predicted) profit of companies in the market segment - Pharma other
ANI Pharmaceuticals is a pharmaceutical company specializing in the production of generics (drug analogs) and branded medications, often for niche markets. The company's model is based on acquiring and relaunching already approved drugs. This chart shows forecasts for the pharmaceutical sector. It helps assess how ANI's strategy for working with existing products impacts its sustainability.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-other&v=1772640770009 "Graph of future (predicted) profits of companies in a market segment - Pharma other")
Future (predicted) profit of the market as a whole
ANI Pharmaceuticals, Inc. produces both branded and generic prescription drugs. This projected profit curve indirectly impacts the pharmaceutical market. Economic pressures are driving demand for more affordable generics, while rising incomes allow patients and healthcare systems to afford more expensive branded medications.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772640770070 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - ANI Pharmaceuticals
ANI Pharmaceuticals is a manufacturer of generic and specialty branded medications. This chart shows how the market values its diversified revenue. It reflects the company's ability to introduce new drugs and compete in the generic segment.
P/S market segment - Pharma other
ANI Pharmaceuticals is a pharmaceutical company specializing in the production of generic and branded drugs, often for niche markets. This chart shows the average valuation in the generics sector. It helps understand how investors view ANI's diversified portfolio and its acquisition and product development strategy.
P/S of the market as a whole
ANI Pharmaceuticals, Inc. produces both branded and generic prescription drugs. The company's business model is diversified, and revenue comes from a wide range of medications. This chart provides an opportunity to assess how the market views this mixed pharmaceutical model compared to companies focused on innovation.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company ANI Pharmaceuticals
ANI Pharmaceuticals is a manufacturer of generic and branded pharmaceuticals. Future revenue depends on the launch of new generic versions of drugs and growth in sales of its own brands. This chart reflects the market's assessment of the company's development portfolio and its ability to successfully launch products in a competitive market.
%20P%2FS%20ANI%20Pharmaceuticals&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-ANI-Pharmaceuticals&v=1772640770444 "The graph of the company's future (projected) P/S ANI Pharmaceuticals")
Future (projected) P/S of the market segment - Pharma other
ANI Pharmaceuticals is a pharmaceutical company specializing in the production of generics (drug analogs) and branded medications, often for niche markets. Its strategy is to acquire and relaunch mature products. This chart shows how the market evaluates its future sales growth model compared to other pharmaceutical companies.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20other&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-other&v=1772640770503 "Future (projected) P/S market segment graph - Pharma other")
Future (projected) P/S of the market as a whole
This chart shows expectations for the pharmaceutical market. For ANI Pharmaceuticals, which specializes in generic and branded drugs, this indicates stable demand. Regardless of general optimism, the need for medications remains high, but economic growth may impact the ability of healthcare systems to afford more expensive medications.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772640770549 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales ANI Pharmaceuticals
ANI Pharmaceuticals is a pharmaceutical company specializing in the production of generics (drug analogs) and branded medications, often for niche markets. This chart shows sales revenue for a broad portfolio of medications. Revenue growth is driven by the launch of new generics and the acquisition of rights to existing medications.
Sales of companies in the market segment - Pharma other
ANI Pharmaceuticals is a manufacturer of generic and branded pharmaceuticals. This chart illustrates the overall dynamics of the pharmaceutical industry. ANI's strategy is to acquire and relaunch undervalued pharmaceutical assets, allowing it to occupy unique niches and ensure stable growth in a competitive environment.
Overall market sales
ANI Pharmaceuticals produces both branded and generic pharmaceuticals. Demand for its products depends on the healthcare system and patent cycles. The overall economic situation, shown in this chart, influences public and private spending on medicines, as well as the overall stability of pharmaceutical supply chains.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company ANI Pharmaceuticals
ANI Pharmaceuticals is a pharmaceutical company specializing in the production of generics (drug analogs) and branded medications, often for niche markets. Its revenue depends on the launch of new generics and stable demand for existing products. This chart shows analysts' expectations for the company's portfolio growth and its ability to compete in the generics market.
%20sales%20of%20the%20company%20ANI%20Pharmaceuticals&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-ANI-Pharmaceuticals&v=1772640770730 "Schedule of future (projected) sales of the company ANI Pharmaceuticals")
Future (projected) sales of companies in the market segment - Pharma other
ANI Pharmaceuticals is a manufacturer of generic and branded pharmaceuticals. This forecast reflects expectations for the entire pharmaceutical industry. It helps understand overall trends in drug pricing and demand for generics, which provides important context for assessing ANI's business model.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-other&v=1772640770754 "Schedule of future (projected) sales of companies in the market segment - Pharma other")
Future (projected) sales of the market as a whole
ANI Pharmaceuticals develops, manufactures, and markets branded and generic prescription drugs. Its business is diversified but dependent on market pricing and the successful launch of new products. The overall economic situation, shown in this chart, impacts healthcare budgets, which in turn influences pricing and demand for pharmaceuticals.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772640770784 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality ANI Pharmaceuticals
ANI Pharmaceuticals specializes in the production and sale of both branded and generic medications. This chart shows the profitability of its diversified pharmaceutical portfolio. The company's profitability depends on successful sales of a wide range of drugs, which helps mitigate risks associated with competition and patent expirations.
Market segment marginality - Pharma other
ANI Pharmaceuticals is a manufacturer of generic and specialty branded pharmaceuticals. The company's profitability depends on the successful launch of new generics and cost management. This metric demonstrates the operational efficiency of its diversified business model compared to other pharmaceutical companies.
Market marginality as a whole
ANI Pharmaceuticals produces both branded and generic prescription drugs. This total market profitability curve indirectly impacts the company through the overall healthcare system. However, its margins are largely dependent on the successful launch of new generics, the acquisition of drug rights, and the efficiency of its own manufacturing.
Employees in the company, segment and market as a whole
Number of employees in the company ANI Pharmaceuticals
ANI Pharmaceuticals produces both branded and generic prescription drugs. This chart shows its manufacturing and sales teams. Headcount changes may reflect new product launches, asset acquisitions, or capacity expansions.
Share of the company's employees ANI Pharmaceuticals within the market segment - Pharma other
ANI Pharmaceuticals specializes in the production of generic and branded pharmaceuticals. This chart shows the company's importance as an employer in the pharmaceutical industry. It reflects the proportion of chemists, technologists, and quality control specialists ANI employs to ensure the production of its wide range of medicines.
Number of employees in the market segment - Pharma other
ANI Pharmaceuticals, Inc. is an integrated pharmaceutical company that develops, manufactures, and markets both branded and generic prescription drugs. The company focuses on niche products. This chart illustrates employment in the pharmaceutical industry, showing how companies with a diversified drug portfolio ensure stability in the labor market.
Number of employees in the market as a whole
ANI Pharmaceuticals is a pharmaceutical company specializing in the production of generic and branded medications. Their business ensures access to medications and promotes stability in the healthcare system. Employment in this sector is less susceptible to economic cycles, as demand for medications remains consistent under all conditions, supporting overall stability.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company ANI Pharmaceuticals (ANIP)
ANI Pharmaceuticals is a manufacturer of generic and branded pharmaceuticals. This chart illustrates the model of a diversified pharmaceutical company. The moderate capitalization per employee reflects the balance between the cost of drug licenses and the need to maintain production facilities and staff for their production and promotion.
%20of%20the%20company%20ANI%20Pharmaceuticals%20(ANIP)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-ANI-Pharmaceuticals-ANIP&v=1772640771627 "Chart of market capitalization per employee (in thousands of dollars) of the company ANI Pharmaceuticals (ANIP)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma other
ANI Pharmaceuticals (ANIP) is a pharmaceutical company specializing in generics (especially complex ones) and branded drugs, often acquiring the rights to older but stable medications. This chart shows the industry average cost per employee. It helps assess how the market values their hybrid business model (generics and branded drugs) and production capacity.
%20by%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-other&v=1772640771659 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma other")
Market capitalization per employee (in thousands of dollars) for the overall market
ANI Pharmaceuticals develops, manufactures, and markets prescription generic and branded medications. This chart shows the market-wide performance assessment of one employee, allowing one to evaluate the diversified pharmaceutical business against the broader economic backdrop.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772640771694 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company ANI Pharmaceuticals (ANIP)
ANI Pharmaceuticals produces generics (copies of drugs) and branded medications. The generics business is characterized by low margins and high production efficiency. This chart shows how successfully the company manages its factories, generating net profit per employee in the face of fierce price competition.
%20Chart%20ANI%20Pharmaceuticals%20(ANIP)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-ANI-Pharmaceuticals-ANIP&v=1772640771710 "Company Profit Per Employee (in thousands of dollars) Chart ANI Pharmaceuticals (ANIP)")
Profit per employee (in thousands of dollars) in the market segment - Pharma other
ANI Pharma is a "specialized" pharmaceutical holding (generics, brand names). This chart shows the benchmark for "Pharma." The average profit per employee in this sector is a balance. "Branded" pharmaceuticals (R&D) have astronomical figures. "Generics" (like ANI) are "commodity," where the benchmark is lower and determined by the efficiency of the plants.
%20in%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-other&v=1772640771722 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma other")
Profit per employee (in thousands of dollars) for the market as a whole
ANI Pharmaceuticals produces generics (drug analogs) and specialized branded medications. It's a hybrid pharmaceutical business. This chart shows the balance between low-margin generics and higher-margin branded products. Efficiency here is determined by the speed of generic market entry and successful brand marketing.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772640771772 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee ANI Pharmaceuticals (ANIP)
ANI Pharmaceuticals is a manufacturer of generic and branded pharmaceuticals. This chart shows productivity in the pharmaceutical industry. It reflects the efficiency of the company's production facilities and its ability to bring new drugs to market while generating stable revenue per employee.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-ANI-Pharmaceuticals-ANIP&v=1772640771827 "Sales chart per company employee ANI Pharmaceuticals (ANIP)")
Sales per employee in the market segment - Pharma other
ANI Pharmaceuticals is a manufacturer of generics (drug analogs) and specialized branded medications. Production efficiency is crucial in this business. This chart shows the average revenue per employee in this segment. It allows us to assess how effectively ANI Pharmaceuticals competes in the generics market compared to other pharmaceutical companies.
Sales per employee for the market as a whole
ANI Pharmaceuticals produces both branded and generic drugs. They have a diversified portfolio. This chart shows the combined efficiency of their manufacturing facilities and commercial team. It reflects the company's ability to generate revenue in two distinct segments of the pharmaceutical market.
Short shares by company, segment and market as a whole
Shares shorted by company ANI Pharmaceuticals (ANIP)
ANI Pharmaceuticals is a manufacturer of generics (analogs) and specialty branded medications. The generics market suffers from fierce price competition and deflation. This chart shows the percentage of "bears" who are skeptical of the success of ANI's new branded medications or expect further price declines for its generics.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-ANI-Pharmaceuticals-ANIP&v=1772640771970 "Short Shares Chart for the Company ANI Pharmaceuticals (ANIP)")
Shares shorted by market segment - Pharma other
ANI Pharmaceuticals, Inc. is a pharmaceutical company specializing in the production of generic and branded drugs, often acquiring the rights to older but essential medications. This indicator reflects the overall volume of short positions in the pharmaceutical sector. An increase in short positions here may indicate that investors perceive risks (such as government pricing pressure) for the entire industry.
Shares shorted by the overall market
ANI Pharmaceuticals (ANIP) is a producer of generic and niche drugs. This Short_All chart shows systemic pessimism. When it rises, even "defensive" sectors like healthcare are sold off. This fear of a correction is weighing on ANIP, despite the stability of its business.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator ANI Pharmaceuticals (ANIP)
ANI Pharmaceuticals specializes in generics and specialty brand-name drugs. Their success depends on the approval of new generics and price competition. This chart measures price momentum, showing when the market is overly positive (overbought) or negative (oversold) in their drug portfolio and future revenue.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-ANI-Pharmaceuticals-ANIP&v=1772640772081 "RSI 14 indicator chart for the company's stock ANI Pharmaceuticals (ANIP)")
RSI 14 Market Segment - Pharma other
ANI Pharmaceuticals is a company specializing in the production of generics (analogs) and branded drugs. Their strategy is to acquire and revive older, but essential, medications. This chart shows the general sentiment in the generics sector and pharmaceutical companies. It helps assess how the market views the industry as a whole and whether the sector is overheated.
RSI 14 for the overall market
ANI Pharmaceuticals (ANIP), a generics manufacturer (copycats of drugs), demonstrates that its business is "defensive." During times of panic and recession, healthcare systems and patients seek savings by switching from expensive brand-name drugs to ANIP's affordable generics, which can even increase its market share.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ANIP (ANI Pharmaceuticals)
ANI Pharmaceuticals specializes in the production of generic drugs and the acquisition of mature branded drugs. This chart shows the average target price assigned by analysts for ANIP, based on their portfolio and M&A strategy.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-ANIP-ANI-Pharmaceuticals&v=1772640772330 "A chart showing analyst consensus forecasts for the expected stock price. ANIP (ANI Pharmaceuticals)")
The difference between the consensus estimate and the actual stock price ANIP (ANI Pharmaceuticals)
ANI Pharmaceuticals (ANIP) is a pharmaceutical company specializing in generics (copies of drugs) and the revival of old, discontinued brand-name drugs. This chart shows the assessment of their business model. It measures the gap between the price and the consensus target, reflecting the potential analysts see in their generic portfolio.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-ANIP-ANI-Pharmaceuticals&v=1772640772511 "A chart showing the difference between the consensus forecast and the actual stock price. ANIP (ANI Pharmaceuticals)")
Analyst consensus forecast for stock prices by market segment - Pharma other
ANI Pharmaceuticals is a specialized pharmaceutical company that produces niche generics and develops its own branded drugs for rare diseases. This chart shows analysts' overall expectations for the entire pharmaceutical sector. It reflects whether experts believe in the strategy of blending stable generics with high-margin brands.
Analysts' consensus forecast for the overall market share price
ANI Pharmaceuticals (ANIP) is a generic company. They produce and relaunch old but essential drugs (generics). This chart of overall market sentiment is important. During a recession (pessimism), investors value the protected and predictable cash flow from generics, which is not dependent on the economy.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index ANI Pharmaceuticals
ANI Pharmaceuticals is a pharmaceutical company specializing in generics. Their model is to produce complex, niche generics (analogs), as well as to acquire and revive older, forgotten brand-name drugs. This chart evaluates their niche strategy, reflecting their ability to find profitable, low-competition niches in the pharmaceutical market.
AKIMA Market Segment Index - Pharma other
ANI Pharmaceuticals (ANIP) is a specialized generics manufacturer; the company focuses on producing complex, niche (and therefore higher-margin) generics and branded drugs. This aggregate metric evaluates companies. The graph shows the sector average. This benchmark provides insight into how ANI's niche (versus mass) generics strategy differentiates it from the average pharmaceutical company.
The AKIM Index for the overall market
ANI Pharmaceuticals is a biopharmaceutical company specializing in niche generics, rare diseases, and established brands. This chart, which reflects the market average, provides a macro backdrop. It helps assess how ANIP, which is growing through acquisitions and product launches, compares to the overall economic trends impacting the healthcare sector.
